Ikena Oncology, Inc. Quarterly Operating Margin in % from Q4 2020 to Q4 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ikena Oncology, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q4 2023.
  • Ikena Oncology, Inc. Operating Margin for the quarter ending December 31, 2023 was -823 %, a 81.4% decline year-over-year.
  • Ikena Oncology, Inc. annual Operating Margin for 2023 was -823 %, a 81.4% decline from 2022.
  • Ikena Oncology, Inc. annual Operating Margin for 2022 was -454 %, a 312% decline from 2021.
  • Ikena Oncology, Inc. annual Operating Margin for 2021 was -110 %, a 77.2% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -823 -369 -81.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -492 -317 -182% Jul 1, 2023 Sep 30, 2023
Q2 2023 -350 -170 -95.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -396 -262 -196% Jan 1, 2023 Mar 31, 2023
Q4 2022 -454 -344 -312% Oct 1, 2022 Dec 31, 2022
Q3 2022 -174 +407 +70% Jul 1, 2022 Sep 30, 2022
Q2 2022 -179 +372 +67.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -134 +365 +73.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -110 +374 +77.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -581 Jul 1, 2021 Sep 30, 2021
Q2 2021 -551 Apr 1, 2021 Jun 30, 2021
Q1 2021 -499 Jan 1, 2021 Mar 31, 2021
Q4 2020 -484 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.